Cardiovascular vulnerability predicts hospitalisation in primary care clinically suspected and confirmed COVID-19

Florien S van Royen1, Linda P T Joosten1, Maarten van Smeden2

  • 1Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

Plos One
|April 11, 2022
PubMed

Insights

Older, male, and cardiovascularly vulnerable patients with COVID-19 symptoms managed in primary care face a higher risk of hospital referral. This study identifies key predictors for hospital admission in these outpatients.

Area of Science:

  • Primary Care Research
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • Hospitalized coronavirus disease 2019 (COVID-19) patients with cardiovascular conditions show increased clinical deterioration.
  • The predictive value of cardiovascular vulnerability for hospital referral in primary care COVID-19 outpatients remains undetermined.

Purpose of the Study:

  • To assess the added value of cardiovascular vulnerability in predicting hospital referral risk among primary care COVID-19 outpatients.
  • To identify patient characteristics associated with increased risk of hospital admission.

Main Methods:

  • Analysis of anonymized electronic medical records from Dutch primary care registries.
  • Development and external validation of a multivariable logistic regression model to predict hospital referral within 90 days.
  • Inclusion of patients from the first wave (n=5,475) for model derivation and the second wave (n=16,693) for validation.

Main Results:

  • The comprehensive model, including cardiovascular conditions and diabetes, outperformed a simpler age/sex model (p<0.001).
  • Older males with multiple cardiovascular conditions and/or diabetes exhibited the highest predicted hospital referral risk (15-20%), compared to the average risk of 5.1%.
  • The model demonstrated good calibration and a temporally validated c-statistic of 0.747 (95%CI 0.729-0.764).

Conclusions:

  • Cardiovascular vulnerability is a significant predictor of hospital referral in primary care COVID-19 outpatients.
  • Older, male, and cardiovascularly compromised individuals with COVID-19 symptoms require closer monitoring in primary care settings.
  • The developed model aids in identifying high-risk patients for timely hospital referral.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
492
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
94
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
99
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
67
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
379